The largest database of trusted experimental protocols

Pcdna3.4 vector

Manufactured by Thermo Fisher Scientific
Sourced in United States, Germany, China

The PcDNA3.4 vector is a plasmid designed for the expression of recombinant proteins in mammalian cells. It contains a strong viral promoter, a polylinker region for insertion of the gene of interest, and selectable markers for antibiotic resistance.

Automatically generated - may contain errors

33 protocols using pcdna3.4 vector

1

Recombinant Protein Expression and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The protein constructs were cloned into pcDNA3.4 vector (GeneArt, Regensburg, Germany), amplified in Escherichia coli and recombinantly expressed using Expi293 cells as described previously [48 (link)]. Seven days after transfection, the proteins were purified using the ÄKTA start system and protein G columns (Cytiva, Uppsala, Sweden) as described previously [49 (link)]. The eluted proteins were aliquoted and stored at − 80 °C until further application.
+ Open protocol
+ Expand
2

Production and Purification of Human GPC2

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full-length human GPC2 and mouse GPC2 ectodomains with C-terminal His6x tags were purchased from R&D Systems (catalogue #2304-GP and 2355-GP, respectively). The gene for the human GPC2 construct GPC224−493 containing a C-terminal His6x tag was codon-optimized for expression in human cells and cloned into the pHLsec vector (GeneArt), as previously described (Raman et al., 2021 (link)). GPC2 point mutants were generated using a KOD-Plus-Mutagenesis Kit following the manufacturer’s instructions. All constructs were transiently transfected and expressed in HEK293F cells and purified using Ni-NTA affinity chromatography, followed by size exclusion chromatography in 20 mM Tris, pH 8.0 and 150 mM NaCl. Genes for the heavy and light chains of the four Fabs were codon-optimized for expression in human cells and cloned into the pcDNA3.4 vector (GeneArt). Fabs were transiently expressed in HEK293F cells and purified using Kappa-Select affinity chromatography (GE Healthcare), followed by size exclusion chromatography in phosphate buffer saline (PBS).
+ Open protocol
+ Expand
3

Engineered scFv8D3-SST Peptide Construct

Check if the same lab product or an alternative is used in the 5 most similar protocols
A scFv consisting of the heavy and light variable domains of the 8D3 antibody 81 (link) was linked to the N-terminal end of the 14 amino acid SST peptide (AGCKNFFWKTFTSC) through an in-house designed linker (APGSYTGSAPG) 43 (link). The two variable regions of 8D3 were connected to each other through a glycine-serine (G4S)3 linker 82 (link). To the N-terminal end of scFv8D3, a poly-6 His-tag (HHHHHH) was added using the same (APGSYTGSAPG) linker. The whole construct was cloned into pcDNA3.4 vector (GeneArt) with a signal peptide on the N-terminal end.
+ Open protocol
+ Expand
4

Recombinant Antibody Production in Expi293F Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Selected antibody sequences were purchased as gBlocks gene fragments (Integrated DNA Technologies) and cloned into a customized pcDNA3.4 vector (Invitrogen) containing human IgG1 or IgA1 Fc regions. VH and VL plasmids were transfected into 30 mL cultures of Expi293F cells (Invitrogen) at a 1:2 ratio and incubated at 37˚C and 8% CO2 for 7 days. The supernatant containing secreted antibodies was collected following centrifugation (1000 g for 10 min at 4˚C), neutralized, and filtered. Antibodies were isolated using Protein G Plus agarose (IgG; Pierce Thermo Fisher Scientific) or Peptide M agarose (IgA; Invitrogen) affinity chromatography, washed with 20 column volumes of PBS, eluted with 100 mM glycine-HCl pH 2.7, and immediately neutralized with 1 M Tris-HCl pH 8.0. The antibodies were then concentrated and buffer exchanged into PBS using 10,000 MWCO Vivaspin centrifugal spin columns (Sartorius).
+ Open protocol
+ Expand
5

Antibody Construct Expression in CHO Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The DNA encoding for antibody constructs (2F10 Fab, 2F10 IgE–IgG, 1B8 IgE–IgG, and 2G1 IgE–IgG) was synthesized by GeneArt (Regensburg, Germany) with codon optimization for expression in CHO cells. IgE–IgG constructs are hybrid monoclonal antibodies that comprise the IgE mAb Fabs (containing the paratope) and the Fc from an IgG as described in Supplementary Material Appendix (Supplemental Material and Methods). The synthesized DNA fragments containing either the light chain or heavy chain were cloned separately into the pcDNA3.4 vector (Invitrogen, San Diego, CA, USA). Transfection grade plasmids were purified, quantified, filtered, and transfected in a 1:1 ratio of heavy to light chains (combined with ExpiFectimine) into ExpiCHO-S cells (Thermo Fisher, Waltham, MA, USA). Full description of culturing conditions and purification of antibody constructs is available in Supplementary Material Appendix (Supplemental Material and Methods).
+ Open protocol
+ Expand
6

Purification of Codon-Optimized ETV1 Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
A codon-optimized sequence of full length ETV1 was cloned into a pcDNA3.4 vector (Invitrogen). Synthesized ETV1 sequence included at C-terminus a FLAG tag sequence and a streptavidin binding peptide sequence (SBP tag). The vector was transfected into HEK293F (Invitrogene) cells adapted to grow in suspension to enable the up scaling of protein production. After 72 hours the cells were harvested and lysed in 1xRIPA buffer supplemented with 2× complete protease inhibitors (Roche). The lysates were cleared by centrifugation at 15,000 rpm for 20 min at 4°C and filtered trough a 0.2 μm filter. The ETV1 protein was bound to a streptavidin column via SBP tag and eluted in 2 mM biotin in PBS buffer.
+ Open protocol
+ Expand
7

Recombinant Antibody Production Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Consensus VH and VL genes were designed and purchased as gBlocks (Integrated DNA Technologies) and cloned into the pcDNA3.4 vector (Invitrogen) containing Oryctolagus cuniculus IgG leader peptide as fusions to human IgG1 and kappa constant regions, respectively. Sequences of both the heavy and the light chain for each antibody variant were confirmed by Sanger sequencing. Plasmids for each antibody variant were transfected into Expi293 cells (Invitrogen) at a 1:3 heavy:light ratio. After incubating at 37 °C with 8% CO2 at 125 rpm for 6 days, the supernatant containing secreted antibodies was collected by centrifugation at 500 g for 15 min at 25°C. Supernatant was passed over a column of 0.5 mL Protein A agarose resin (Thermo Scientific) three times to ensure efficient binding. After washing with 20 column volumes of PBS, antibodies were eluted with 3 mL 100 mM citric acid pH 3.0 and immediately neutralized with 500 μL 1 M Tris pH 8.0. Antibodies were buffer exchanged into PBS, pH 7.4 utilizing Amicon Ultra-30 centrifugal spin columns (Millipore) for storage and subsequent use.
+ Open protocol
+ Expand
8

Antibody Production and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sequences of variable heavy- and light-chain regions for the chosen antibodies were codon optimized and synthesized as eBlocks (Integrated DNA Technologies). The synthetic genes were cloned into a pcDNA3.4 vector (Invitrogen) containing human IgG1 heavy-chain and kappa or lambda light-chain constant regions, respectively (16 (link), 49 (link)). Heavy- and light-chain plasmids for each monoclonal antibody were cotransfected into Expi293F cells (Thermo Fisher Scientific). After incubating for 5 days at 37°C with 8% CO2, the supernatant containing secreted antibodies was centrifuged at 4,000 × g for 15 min at 4°C, filtered through 0.45-μm syringe filters (Sartorius), and passed three times over a column with 1 mL protein G agarose resin (Pierce). After washing the column with 20 column volumes of PBS, antibodies were eluted with 10 mL 100 mM glycine-HCl (pH 2.7) and immediately neutralized with 1.5 mL of 1 M Tris-HCl (pH 8.0). Antibodies were buffer exchanged into DPBS, utilizing Amicon ultra-30 centrifugal spin columns (Millipore).
+ Open protocol
+ Expand
9

Recombinant Antibody Expression Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Selection of antibody sequences for recombinant expression was based on the combination of VH:VL-paired databases and proteomics data. First, we identified antibody clonotypes identified in the proteomics analysis and searched for the same clonotype in the VH:VL-paired database. Full-length heavy and light chain sequences were then determined from the paired sequencing database.
These genes were purchased as gBlocks (Integrated DNA Technologies) and cloned into the pcDNA3.4 vector (Invitrogen). Heavy and light chain plasmids for each monoclonal antibody were transfected into Expi293 cells (Invitrogen) at a 1:3 ratio. After incubating for 5 days at 37°C with 8% CO2, the supernatant containing secreted antibodies was collected by centrifugation at 500×g for 15 min at RT. Supernatant was passed over a column with 0.5 ml Protein A agarose resin (Thermo Scientific) three times to ensure efficient capture. After washing the column with 20 cv of PBS, antibodies were eluted with 3 ml 100 mM glycine-HCl, pH 2.7 and immediately neutralized with 1 ml 1 M Tris-HCl, pH 8.0. Antibodies were buffer-exchanged into PBS utilizing Amicon Ultra-30 centrifugal spin columns (Millipore).
+ Open protocol
+ Expand
10

Generation and Purification of Anti-Nectin-4 Antibody

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genes of anti Nectin-4 antibody were generated (General Biosystems, Anhui, China), and subcloned into a pCDNA 3.4 vector (Invitrogen). HEK 293F cells were transiently transfected with plasmids loading antibody genes and cultured. The supernatant containing anti Nectin-4 antibody was collected for antibody extraction and purification as previously described [37 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!